BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dende C, Meena J, Nagarajan P, Panda AK, Rangarajan PN, Padmanaban G. Simultaneously targeting inflammatory response and parasite sequestration in brain to treat Experimental Cerebral Malaria. Sci Rep 2015;5:12671. [PMID: 26227888 DOI: 10.1038/srep12671] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Keita Alassane S, Nicolau-Travers ML, Menard S, Andreoletti O, Cambus JP, Gaudre N, Wlodarczyk M, Blanchard N, Berry A, Abbes S, Colongo D, Faye B, Augereau JM, Lacroux C, Iriart X, Benoit-Vical F. Young Sprague Dawley rats infected by Plasmodium berghei: A relevant experimental model to study cerebral malaria. PLoS One 2017;12:e0181300. [PMID: 28742109 DOI: 10.1371/journal.pone.0181300] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
2 Albalawi AE, Alanazi AD, Sharifi I, Ezzatkhah F. A Systematic Review of Curcumin and its Derivatives as Valuable Sources of Antileishmanial Agents. Acta Parasitol 2021;66:797-811. [PMID: 33770343 DOI: 10.1007/s11686-021-00351-1] [Reference Citation Analysis]
3 Khairani S, Fauziah N, Wiraswati HL, Panigoro R, Setyowati EY, Berbudi A. The Potential use of a Curcumin-Piperine Combination as an Antimalarial Agent: A Systematic Review. J Trop Med 2021;2021:9135617. [PMID: 34671402 DOI: 10.1155/2021/9135617] [Reference Citation Analysis]
4 Castaño Barrios L, Da Silva Pinheiro AP, Gibaldi D, Silva AA, Machado Rodrigues E Silva P, Roffê E, da Costa Santiago H, Tostes Gazzinelli R, Mineo JR, Silva NM, Lannes-Vieira J. Behavioral alterations in long-term Toxoplasma gondii infection of C57BL/6 mice are associated with neuroinflammation and disruption of the blood brain barrier. PLoS One 2021;16:e0258199. [PMID: 34610039 DOI: 10.1371/journal.pone.0258199] [Reference Citation Analysis]
5 Gomes GS, Maciel TR, Piegas EM, Michels LR, Colomé LM, Freddo RJ, Ávila DSD, Gundel A, Haas SE. Optimization of Curcuma Oil/Quinine-Loaded Nanocapsules for Malaria Treatment. AAPS PharmSciTech 2018;19:551-64. [DOI: 10.1208/s12249-017-0854-6] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
6 Burrack KS, Huggins MA, Taras E, Dougherty P, Henzler CM, Yang R, Alter S, Jeng EK, Wong HC, Felices M, Cichocki F, Miller JS, Hart GT, Johnson AJ, Jameson SC, Hamilton SE. Interleukin-15 Complex Treatment Protects Mice from Cerebral Malaria by Inducing Interleukin-10-Producing Natural Killer Cells. Immunity 2018;48:760-772.e4. [PMID: 29625893 DOI: 10.1016/j.immuni.2018.03.012] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 6.8] [Reference Citation Analysis]
7 Maurizio PL, Fuseini H, Tegha G, Hosseinipour M, De Paris K. Signatures of divergent anti-malarial treatment responses in peripheral blood from adults and young children in Malawi. Malar J 2019;18:205. [PMID: 31234875 DOI: 10.1186/s12936-019-2842-7] [Reference Citation Analysis]
8 Dwivedi H, Singh SK, Chauhan BS, Gunjan S, Tripathi R. Potential cerebral malaria therapy: intramuscular arteether and vitamin D co-administration. Parasitology 2016;143:1557-68. [DOI: 10.1017/s0031182016001207] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
9 Ataide BJA, Kauffmann N, Mendes NSF, Torres MLM, Dos Anjos LM, Passos ADCF, de Moraes SAS, Batista EJO, Herculano AM, Oliveira KRHM. Melatonin Prevents Brain Damage and Neurocognitive Impairment Induced by Plasmodium Berghei ANKA Infection in Murine Model of Cerebral Malaria. Front Cell Infect Microbiol 2020;10:541624. [PMID: 33102250 DOI: 10.3389/fcimb.2020.541624] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
10 Efferth T, Oesch F. The immunosuppressive activity of artemisinin-type drugs towards inflammatory and autoimmune diseases. Med Res Rev 2021. [PMID: 34288018 DOI: 10.1002/med.21842] [Reference Citation Analysis]
11 Golenser J, Salaymeh N, Higazi AA, Alyan M, Daif M, Dzikowski R, Domb AJ. Treatment of Experimental Cerebral Malaria by Slow Release of Artemisone From Injectable Pasty Formulation. Front Pharmacol 2020;11:846. [PMID: 32595499 DOI: 10.3389/fphar.2020.00846] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
12 Padmanaban G, Rangarajan PN. Curcumin as an Adjunct Drug for Infectious Diseases. Trends Pharmacol Sci 2016;37:1-3. [PMID: 26521094 DOI: 10.1016/j.tips.2015.09.007] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 2.6] [Reference Citation Analysis]
13 Dende C, Meena J, Nagarajan P, Nagaraj VA, Panda AK, Padmanaban G. Nanocurcumin is superior to native curcumin in preventing degenerative changes in Experimental Cerebral Malaria. Sci Rep 2017;7:10062. [PMID: 28855623 DOI: 10.1038/s41598-017-10672-9] [Cited by in Crossref: 52] [Cited by in F6Publishing: 42] [Article Influence: 10.4] [Reference Citation Analysis]
14 Varo R, Crowley VM, Sitoe A, Madrid L, Serghides L, Kain KC, Bassat Q. Adjunctive therapy for severe malaria: a review and critical appraisal. Malar J 2018;17:47. [PMID: 29361945 DOI: 10.1186/s12936-018-2195-7] [Cited by in Crossref: 42] [Cited by in F6Publishing: 31] [Article Influence: 10.5] [Reference Citation Analysis]
15 Velasques K, Maciel TR, de Castro Dal Forno AH, Teixeira FEG, da Fonseca AL, Varotti FP, Fajardo AR, Ávila DS, Haas SE. Co-nanoencapsulation of antimalarial drugs increases their in vitro efficacy against Plasmodium falciparum and decreases their toxicity to Caenorhabditis elegans. Eur J Pharm Sci 2018;118:1-12. [PMID: 29550283 DOI: 10.1016/j.ejps.2018.03.014] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 5.5] [Reference Citation Analysis]